Skip to content

Clinical trials

Completed Pulmonary Emphysema trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Emphysema Status: Completed Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20063
20073
20081
20092
20121
20131
20141
20151
20161
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aeris Therapeutics4
Grifols Therapeutics LLC4
AstraZeneca1
Boehringer Ingelheim1
Kamada, Ltd.1
Mayo Clinic1
Mesoblast, Inc.1
National Center for Complementary and Integrative Health (NCCIH)1
Olympus Corporation of the Americas1
ROX Medical, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Emphysema18
Pulmonary Disease, Chronic Obstructive13
Emphysema6
Lung Diseases6
Bronchitis, Chronic5
alpha 1-Antitrypsin Deficiency5
Lung Diseases, Obstructive3
Respiratory Tract Diseases3
Pathologic Processes2
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.